P1‐023: MASS SPECTROMETRY–BASED MEASUREMENT OF LONGITUDINAL CSF TAU IDENTIFIES DIFFERENT PHOSPHORYLATED SITES THAT TRACK DISTINCT STAGES OF PRESYMPTOMATIC DOMINANTLY INHERITED AD-Reference-Cited by-同舟云学术

P1‐023: MASS SPECTROMETRY–BASED MEASUREMENT OF LONGITUDINAL CSF TAU IDENTIFIES DIFFERENT PHOSPHORYLATED SITES THAT TRACK DISTINCT STAGES OF PRESYMPTOMATIC DOMINANTLY INHERITED AD

Published:2006-07 Issue:7S_Part_4 Volume:14 Page:
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Barthélemy Nicolas R.¹,Li Yan²,Wang Guoqiao²,Fagan Anne M.³⁴,Morris John C.³,Benzinger Tammie L.S.²⁵,Goate Alison²,Hassenstab Jason⁶,Xiong Chengjie²,Sato Chihiro²,Bateman Randall J.²⁵,McDade Eric²⁵

Affiliation:

1. Washington UniversitySt. LouisMOUSA

2. Washington University School of MedicineSt. LouisMOUSA

3. Knight Alzheimer Disease Research CenterSaint LouisMOUSA

4. Washington University School of MedicineSaint LouisMOUSA

5. Knight Alzheimer's Disease Research CenterSt. LouisMOUSA

6. Washington University in St. Louis School of MedicineSt. LouisMOUSA

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Clinical Neurology,Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1016/j.jalz.2018.06.024

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proteomic Discovery and Validation of Novel Fluid Biomarkers for Improved Patient Selection and Prediction of Clinical Outcomes in Alzheimer’s Disease Patient Cohorts;Proteomes;2022-08-01

2. Blood plasma phosphorylated-tau isoforms track CNS change in Alzheimer’s disease;Journal of Experimental Medicine;2020-07-28